May 15, 2022

Why CTI Biopharma Stock Is Surging Today

What happened
Shares of CTI BioPharma (NASDAQ: CTIC) moved sharply higher after the drugmaker reported first-quarter results Friday morning. Investors were pleased with the initial sales figures for Vonjo, its first approved drug, and pushed the stock price 20.8% higher as of 11:

This post was originally published on this site

Sign Up To Get FREE News, Tips and Offers!

X